Difference between revisions of "Hoffman DL"
From Bioblast
Beno Marija (talk | contribs) |
Beno Marija (talk | contribs) |
||
| Line 14: | Line 14: | ||
== Participated at == | == Participated at == | ||
::::*[[IOC65]] | ::::*[[IOC65|IOC65 Schroecken AT]] | ||
Revision as of 17:35, 12 February 2018
| Name | Hoffman David L, |
|---|---|
| Institution | Lycera Corporation |
| Address | 46701 N. Commerce Center Dr., Suite C, 48170 |
| City | Plymouth |
| State/Province | Michigan (MI) |
| Country | USA |
| [email protected] | |
| Weblink | |
| O2k-Network Lab | US MI Ann Arbor Glick GD |
Labels:
Publications
| Published | Reference | |
|---|---|---|
| Hom 2011 Dev Cell | 2011 | Hom JR, Quintanilla RA, Hoffman DL, de Mesy Bentley KL, Molkentin JD, Sheu SS, Porter GA Jr (2011) The permeability transition pore controls cardiac mitochondrial maturation and myocyte differentiation. Dev Cell 469-78. |
| Hoffman 2009 J Biol Chem | 2009 | Hoffman DL, Brookes PS (2009) Oxygen sensitivity of mitochondrial reactive oxygen species generation depends on metabolic conditions. J Biol Chem 284:16236-45. |
| Hoffman 2007 Am J Physiol Heart Circ Physiol | 2007 | Hoffman DL, Salter JD, Brookes PS (2007) Response of mitochondrial reactive oxygen species generation to steady-state oxygen tension: implications for hypoxic cell signaling. Am J Physiol Heart Circ Physiol 292:H101-8. |
Abstracts
- * Mitochondrial ROS production, open flow respirometry, mitochondrial therapeutics
